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INTRODUCTION 
Acrylic based bone cements are popular in orthopedic surgery due to the 
wide variety of uses and high degree of customization 
Bone cements are used to treat vertebral fractures due to osteoporosis 
and metastatic disease 
There is also utility for mixing chemotherapeutic agents with bone 
cement and using it as a local delivery system in vivo for bone cancer 
Elution profiles of bone cement can be modified by adding soluble fillers 
such as polyethylene glycol (PEG) 
Addition of PEG will increase elution time of chemotherapy agents, but it 
will also cause the mechanical properties of the cement to be changed 
Currently there isn’t a reliable way for a surgeon to prepare a 
customized cement intraoperatively and predict its mechanical properties 
 
 
 
 
 
 
 
 
OBJECTIVES 
Determine the change in mechanical properties of the cements after drug 
elution 
 
METHODS 
Confidence Ultra, Vertebroplastic (Depuy Spine, Inc), and Palacos cement 
(Zimmer Inc.) were used and mixed with varying amounts (0–50%) of PEG 
(MW 8,000) and chemotherapy agents (Methotrexate or doxorubicin).  
Cylindrical Bone cement specimens were placed in a saline solution for 
one year.  After 1 year, the specimens (3 per group) were tested in 
compression at 1 mm/min until failure.   Failure was established by 
watching the stress strain curve for the sample reach plastic deformation.  
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 1: Modulus of Bone Cement Samples   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Figure 2: Compression Strength of Bone Cement Samples 
 
 
 
 
 
 
 
 
 
 
 
 
                        
   Table 1. Mechanical Properties of Bone Cement Samples 
DISCUSSION 
Palacos and Vertebroplastic retained their properties better than 
Confidence 
Increasing the amount of soluble filler resulted in a decreased modulus 
and compression strength (Figures 1&2) in all three bone cement 
samples as expected 
Despite elution in a liquid medium for one year the cements retained 
adequate modulus of elasticity and compression strength 
Other than knowing that the addition of soluble fillers will lower 
mechanical properties, it is  difficult to know the exact combination of 
cement and filler to make a material with the desired mechanical 
properties for the patient 
The best was to guarantee the appropriate properties, and drug elution 
profile of a bone cement would be for a company to provide a 
commercially available product with known mechanical properties 
 
CONCLUSION 
When using bone cements clinically it is important to remember that 
combining soluble fillers enhances drug elution at the expense of 
mechanical properties.  
 
Additionally, the mechanical properties of different commercially available 
bone cements behave differently with similar percentages of soluble filler 
and drug added.  This shows the difficulty in predicting in vivo changes in 
mechanical properties of bone cement intraoperatively.  
 
Many surgeons prepare the bone cement/chemotherapy mixtures 
intraoperatively, however our experiments show the difficulty in predicting 
the exact behavior of this new combination as far as mechanical 
properties are concerned. This elucidates the need for well characterized 
bone cement optimized for chemotherapy drug delivery.  
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 Metastasis to L4 vertebra 
Modulus MPa 
Compression 
Strength MPa 
Retained Modulus Retained Strength 
Palacos 100/0 1186.91 75.32 
Palacos 80/20 862.76 50.39 73% 67% 
Palacos 50/50 418.29 24.47 35% 32% 
Vert 100/0 894.43 87.41 
Vert 80/20 560.49 53.88 63% 62% 
Vert 50/50 350.38 33.42 39% 38% 
Conf 100/0 996.61 57.62 
Conf 80/20 466.65 26.69 47% 46% 
Conf 50/50 173.50 12.91 17% 22% 
Electromechanical  testing 
machine 
Vertebroplasty (injection of 
chemotherapy bone 
cement) 
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